LLY

916.07

-0.02%↓

UNH

566.13

-0.87%↓

NVO

118.17

+0.23%↑

JNJ

164.55

+0.16%↑

ABBV

188.57

-1%↓

LLY

916.07

-0.02%↓

UNH

566.13

-0.87%↓

NVO

118.17

+0.23%↑

JNJ

164.55

+0.16%↑

ABBV

188.57

-1%↓

LLY

916.07

-0.02%↓

UNH

566.13

-0.87%↓

NVO

118.17

+0.23%↑

JNJ

164.55

+0.16%↑

ABBV

188.57

-1%↓

LLY

916.07

-0.02%↓

UNH

566.13

-0.87%↓

NVO

118.17

+0.23%↑

JNJ

164.55

+0.16%↑

ABBV

188.57

-1%↓

LLY

916.07

-0.02%↓

UNH

566.13

-0.87%↓

NVO

118.17

+0.23%↑

JNJ

164.55

+0.16%↑

ABBV

188.57

-1%↓

Search

Accuray Inc

Suletud

Sektor Tervishoid

1.89 1.07

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

1.84

Max

1.89

Põhinäitajad

By Trading Economics

Müük

107M

Aktsiakasum

-0.1

Soovitused

By TipRanks

Soovitused

Tugev "osta" hinnang

12 kuu keskmine prognoos

+238.5 upside

Dividendid

By Dow Jones

Järgmine tulemuste avaldamine

5. nov 2024

Turustatistika

By TradingEconomics

Turukapital

1M

239M

Eelmine avamishind

0.82

Eelmine sulgemishind

1.89

Uudiste sentiment

By Acuity

20%

80%

36 / 366 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Very Strong Bullish Evidence

Accuray Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

16. okt 2024, 23:50 UTC

Kuumad aktsiad

Stocks to Watch: Tesla, CSX, Alcoa

16. okt 2024, 23:30 UTC

Omandamised, ülevõtmised, äriostud

Discover Financial, SEC Working to Resolve Misclassification Matter -- Update

16. okt 2024, 20:35 UTC

Tulu

CSX Posts Higher Revenue, Profit in 3Q on Increased Volume

16. okt 2024, 23:59 UTC

Market Talk
Omandamised, ülevõtmised, äriostud

Global Equities Roundup: Market Talk

16. okt 2024, 23:59 UTC

Market Talk
Omandamised, ülevõtmised, äriostud

Woodside's LNG Deal Edges Ammonia Play, Bull Says -- Market Talk

16. okt 2024, 23:53 UTC

Market Talk

Gold Steady Ahead of Key U.S. Economic Data -- Market Talk

16. okt 2024, 23:50 UTC

Market Talk

Santos's Pikka Cost Rise Expected, But Builds Debt Pain -- Market Talk

16. okt 2024, 22:46 UTC

Peamised uudised

RTX Agrees to More Than $950 Million in Penalties to Settle Qatar Bribery, Contract Fraud Charges -- 2nd Update

16. okt 2024, 22:33 UTC

Peamised uudised

RTX Agrees to More Than $950 Million in Penalties to Settle Qatar Bribery, Contract Fraud Charges -- Update

16. okt 2024, 22:18 UTC

Peamised uudised

Elon Musk Taps Longtime Aide to Oversee Tesla's Operations in North America, Europe, Sources Say -- WSJ

16. okt 2024, 21:32 UTC

Tulu

Morgan Stanley's Bumper Earnings Power Stock to Record High -- Barrons.com

16. okt 2024, 21:20 UTC

Peamised uudised

China Security Group Urges Review of Intel's Chips as Tech Tension With U.S. Rises -- 2nd Update

16. okt 2024, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

16. okt 2024, 20:50 UTC

Market Talk
Omandamised, ülevõtmised, äriostud

Health Care Roundup: Market Talk

16. okt 2024, 20:16 UTC

Peamised uudised

Dow Edges Up; Morgan Stanley Gains on Strong Earnings Headline -- WSJ

16. okt 2024, 20:12 UTC

Tulu

Kinder Morgan Cites Lower Than Budgeted Commodity Prices and Start-Up Delays on RNG Facilities >KMI

16. okt 2024, 20:11 UTC

Tulu

Kinder Morgan Expects Adj EBITDA to Be Up 5% and Adj EPS to Be Up 9% for FY Vs 2023 >KMI

16. okt 2024, 20:11 UTC

Tulu

Kinder Morgan Now Expects to Be Below Budget on Adj EBITDA by About 2% and on Adj EPS by About 4% >KMI

16. okt 2024, 20:10 UTC

Tulu

Kinder Morgan Expects to Declare Dividends of $1.15 Per Shr for 2024 >KMI

16. okt 2024, 20:10 UTC

Tulu

Kinder Morgan Budgeted 2024 DCF of $5 B, or $2.26 Per Share >KMI

16. okt 2024, 20:10 UTC

Tulu

Kinder Morgan Project Backlog at End of 3Q Was $5.1 B >KMI

16. okt 2024, 20:07 UTC

Tulu

Kinder Morgan: Final Investment Decision Reached for Gulf Coast Express Pipeline Expansion >KMI

16. okt 2024, 20:06 UTC

Tulu

CSX Corp: 4Q Volume Expected to Grow Modestly>CSX

16. okt 2024, 20:05 UTC

Tulu

CSX Corp: Lower revenue, Storm Impacts May Reduce Sequential Operating Margin in 4Q, Limiting 2H Margin Growth >CSX

16. okt 2024, 20:05 UTC

Tulu

Kinder Morgan 3Q Rev $3.7B >KMI

16. okt 2024, 20:05 UTC

Tulu

Kinder Morgan 3Q Adj EPS 25c >KMI

16. okt 2024, 20:05 UTC

Tulu

Kinder Morgan 3Q EPS 28c >KMI

16. okt 2024, 20:05 UTC

Tulu

Kinder Morgan 3Q Net $625M >KMI

16. okt 2024, 20:05 UTC

Tulu

Kinder Morgan Sees FY EPS $1.22 >KMI

16. okt 2024, 20:05 UTC

Tulu

Kinder Morgan Sees FY Net $2.7B >KMI

Võrdlus sarnastega

Hinnamuutus

Accuray Inc Prognoos

Hinnasiht

By TipRanks

238.5% tõus

12 kuu keskmine prognoos

Keskmine 6.33 USD  238.5%

Kõrge 7 USD

Madal 6 USD

Põhineb 3 Wall Streeti analüütiku instrumendi Accuray Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

3 ratings

3

Osta

0

Hoia

0

Müü

Tehniline skoor

By Trading Central

1.81 / 1.9Toetus ja vastupanu

Lühikene perspektiiv

Very Strong Bullish Evidence

Keskpikk perspektiiv

Bearish Evidence

Pikk perspektiiv

Bearish Evidence

Sentiment

By Acuity

36 / 366 Pingereas Tervishoid

Uudiste sentiment

Väga tugevad tõusu märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Üle keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Accuray Inc

Accuray Incorporated is a radiation therapy company. The Company develops, manufactures, sells and supports market-changing solutions that are designed to deliver radiation treatments. The Company's technologies include the CyberKnife and TomoTherapy platforms, including the Radixact System. The CyberKnife and TomoTherapy platform, which are designed to deliver treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT) and adaptive radiation therapy (ART). The CyberKnife Systems are robotic systems that are used to treat various types of cancer and tumors throughout the body. The CyberKnife Systems track, detect and correct for tumor and patient movement in real-time during the procedure. The TomoTherapy Systems include the TomoTherapy H Series with configuration options of TomoH, TomoHD and TomoHDA.